• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雷尼替丁、马来酸多潘立酮及雷尼替丁 + 马来酸多潘立酮用于反流性食管炎短期治疗的比较

Comparison of ranitidine, domperidone maleate and ranitidine + domperidone maleate in the short-term treatment of reflux oesophagitis.

作者信息

Masci E, Testoni P A, Passaretti S, Guslandi M, Tittobello A

出版信息

Drugs Exp Clin Res. 1985;11(10):687-92.

PMID:3915459
Abstract

In the treatment of reflux oesophagitis, either drugs preventing regurgitation of gastric juice in the lower oesophagus or pharmacological agents increasing the pH of the refluxing material are employed. In the present study 45 outpatients with reflux oesophagitis were randomly treated with either ranitidine (150 mg b.i.d.) or domperidone maleate (20 mg t.i.d.) or both drugs for six weeks. Before and after treatment the severity of dyspeptic symptoms and the grade of endoscopic and histological changes were assessed. The three therapeutic regimens were significantly and equally effective in inducing symptomatic relief and promoting endoscopic and histological disappearance or improvement of oesophagitis. The combined use of ranitidine and domperidone maleate failed to show any additional benefit compared with treatment with either drug alone.

摘要

在反流性食管炎的治疗中,要么使用防止胃液反流至食管下段的药物,要么使用提高反流物质pH值的药物。在本研究中,45例反流性食管炎门诊患者被随机分为三组,分别接受雷尼替丁(150毫克,每日两次)、马来酸多潘立酮(20毫克,每日三次)治疗,或两种药物联合治疗,为期六周。治疗前后评估消化不良症状的严重程度以及内镜和组织学变化的分级。三种治疗方案在缓解症状、促进内镜及组织学上食管炎的消失或改善方面均有显著且同等的效果。与单独使用任一药物治疗相比,雷尼替丁和马来酸多潘立酮联合使用未显示出任何额外益处。

相似文献

1
Comparison of ranitidine, domperidone maleate and ranitidine + domperidone maleate in the short-term treatment of reflux oesophagitis.雷尼替丁、马来酸多潘立酮及雷尼替丁 + 马来酸多潘立酮用于反流性食管炎短期治疗的比较
Drugs Exp Clin Res. 1985;11(10):687-92.
2
Ranitidine vs metoclopramide in the medical treatment of reflux esophagitis.雷尼替丁与甲氧氯普胺在反流性食管炎药物治疗中的比较
Hepatogastroenterology. 1983 Jun;30(3):96-8.
3
[Drug therapy of gastroesophageal reflux (a prospective controlled clinical trial)].[胃食管反流的药物治疗(一项前瞻性对照临床试验)]
Orv Hetil. 1998 May 3;139(18):1077-81.
4
Short-term treatment of reflux oesophagitis with ranitidine 300 mg nocte. Italian multicentre study.
Hepatogastroenterology. 1987 Aug;34(4):155-9.
5
Combination of ranitidine and cisapride in the treatment of reflux oesophagitis.雷尼替丁与西沙必利联合治疗反流性食管炎。
Eur J Gastroenterol Hepatol. 1995 Sep;7(9):817-22.
6
Cisapride versus ranitidine in the treatment of reflux esophagitis.
Hepatogastroenterology. 1988 Jun;35(3):125-7.
7
[Reduced suppression of gastric acid by ranitidine in severe reflux esophagitis. A pilot study].
Z Gastroenterol. 1988 Jul;26(7):345-50.
8
Short and long-term effect of two different dosages of ranitidine in the therapy of reflux oesophagitis.两种不同剂量雷尼替丁治疗反流性食管炎的短期和长期疗效
Ital J Gastroenterol. 1990 Feb;22(1):28-32.
9
[Cimetidine and ranitidine in the treatment of reflux esophagitis].西咪替丁和雷尼替丁治疗反流性食管炎
Z Gastroenterol. 1984 Aug;22(8):373-8.
10
A comparison of the clinical efficacy of ranitidine and sucralfate in reflux oesophagitis.
J Assoc Physicians India. 1992 Mar;40(3):162-3.

引用本文的文献

1
Evaluation of the Additive Effect of Domperidone on Patients with Refractory Gastroesophageal Reflux Disease; A Randomized Double Blind Clinical Trial.多潘立酮对难治性胃食管反流病患者的附加效应评估;一项随机双盲临床试验。
Middle East J Dig Dis. 2019 Jan;11(1):24-31. doi: 10.15171/mejdd.2018.124. Epub 2018 Nov 14.
2
Gastro-oesophageal reflux disease: beyond proton pump inhibitor therapy.胃食管反流病:质子泵抑制剂治疗之外。
Drugs. 2011 Dec 24;71(18):2381-9. doi: 10.2165/11597300-000000000-00000.
3
Meta-Analyses of Cisapride, Omeprazole and Ranitidine in the Treatment of GORD: Implications for Treating Patient Subgroups.
西沙必利、奥美拉唑和雷尼替丁治疗 GORD 的荟萃分析:对治疗亚组患者的意义。
Clin Drug Investig. 1998;16(1):9-18. doi: 10.2165/00044011-199816010-00002.
4
A systematic review of symptomatic outcomes used in oesophagitis drug therapy trials.一项关于食管炎药物治疗试验中使用的症状性结局的系统评价。
Gut. 2004 May;53 Suppl 4(Suppl 4):iv58-65. doi: 10.1136/gut.2003.034371.
5
Economic evaluation of long-term management strategies for erosive oesophagitis.糜烂性食管炎长期管理策略的经济学评估
Pharmacoeconomics. 1999 Dec;16(6):679-97. doi: 10.2165/00019053-199916060-00007.
6
Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.雷尼替丁。对其药效学、药代动力学特性以及在消化性溃疡疾病和其他相关疾病中的治疗应用的最新综述。
Drugs. 1989 Jun;37(6):801-70. doi: 10.2165/00003495-198937060-00003.